Bevacizumab Reduces S100A9-Positive MDSCs Linked to Intracranial Control in Patients with EGFR-Mutant Lung Adenocarcinoma - Concepedia

Concepedia

Publication | Open Access

Bevacizumab Reduces S100A9-Positive MDSCs Linked to Intracranial Control in Patients with EGFR-Mutant Lung Adenocarcinoma

DOI Full Paper Access

77

Citations

25

References

2018

Year

Po‐Hao Feng, Kuan-Yuan Chen, Yu‐Chen Huang, Ching-Shan Luo, Shen Ming Wu, Tzu-Tao Chen, Chun-Nin Lee, Chi‐Tai Yeh, Hsiao‐Chi Chuang, Chia‐Li Han,

Journal of Thoracic Oncology

MedicineImmunologyEgfr-mutant Lung AdenocarcinomaPathologyImmune Checkpoint InhibitorIntracranial ControlCancer TreatmentCancer GeneticsOncologyLung CancerCancer Research

References

	Year	Citations

Page 1

Page 1